BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32266979)

  • 21. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
    Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
    Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
    Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
    Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
    Stokkevåg CH; Engeseth GM; Hysing LB; Ytre-Hauge KS; Ekanger C; Muren LP
    Acta Oncol; 2015; 54(9):1317-25. PubMed ID: 26230629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of database quality in knowledge-based treatment planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Pract Radiat Oncol; 2018; 8(6):437-444. PubMed ID: 29730280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma.
    Gao M; Li Q; Ning Z; Gu W; Huang J; Mu J; Pei H
    Med Dosim; 2016; 41(2):131-5. PubMed ID: 26920244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
    Alongi F; Cozzi L; Fogliata A; Iftode C; Comito T; Clivio A; Villa E; Lobefalo F; Navarria P; Reggiori G; Mancosu P; Clerici E; Tomatis S; Taverna G; Graziotti P; Scorsetti M
    Anticancer Res; 2013 Oct; 33(10):4537-43. PubMed ID: 24123027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
    Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
    Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.
    Cakir A; Akgun Z; Fayda M; Agaoglu F
    Asian Pac J Cancer Prev; 2015; 16(8):3365-70. PubMed ID: 25921146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
    Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
    Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
    Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
    J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology.
    Her EJ; Ebert MA; Kennedy A; Reynolds HM; Sun Y; Williams S; Haworth A
    Phys Med Biol; 2021 Feb; 66(4):045007. PubMed ID: 32408293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.
    Rechner LA; Howell RM; Zhang R; Etzel C; Lee AK; Newhauser WD
    Phys Med Biol; 2012 Nov; 57(21):7117-32. PubMed ID: 23051714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
    Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic collimator angle adjustments during volumetric modulated arc therapy to account for prostate rotations.
    de Boer J; Wolf AL; Szeto YZ; van Herk M; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1009-16. PubMed ID: 25618782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm.
    Chow JCL; Jiang R; Xu L
    Med Dosim; 2020 Spring; 45(1):14-18. PubMed ID: 31103251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.